Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page
- Check4 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the Italy locations list.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLocation entry updated from Napoli, Italy, 80131 to Naples, Italy, 80131. Revision label updated to v3.5.0, replacing the previous v3.4.3 entry.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedThe revision label updated from v3.4.1 to v3.4.2. No study details or results are affected.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check83 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no substantive changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.